88 FR 100 pgs. 33616-33617 - National Center for Advancing Translational Sciences; Notice of Closed Meeting
Type: NOTICEVolume: 88Number: 100Pages: 33616 - 33617
Pages: 33616, 33617FR document: [FR Doc. 2023-11049 Filed 5-23-23; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: National Institutes of Health
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
[top] The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material,
Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; RFA-TR-22-032: Botulinum Toxin Potency Assay using Tissue Chips.
Date: June 14, 2023.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Room 1037, Bethesda, MD 20892.
Contact Person: Rahat (Rani) Khan, Ph.D., Scientific Review Officer, Office of Scientific Review, National Center for Advancing Translational Sciences, 6701 Democracy Boulevard, Room 1078, Bethesda, MD 20892, 301-594-7319, Rahat.khan@nih.gov .
(Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B-Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS)
Dated: May 18, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-11049 Filed 5-23-23; 8:45 am]
BILLING CODE 4140-01-P